2m 2m 2m 2m 2m 2m 2m
Phibro Animal-A (PAHC)
NASDAQ
$35.60-$0.02 (-0.07%)
Price as of Sep 11, 2026 7:42 PM EDT- $772.0MMarket Cap
- -8.98%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Phibro Animal-A (PAHC)
$35.60-$0.02 (-0.07%)
PAHC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.62 | ||
Change | -$0.96 (-2.62%) | ||
Open | $36.99 | ||
High | $37.66 | ||
Low | $35.51 | ||
Previous Close | $36.58 | ||
Volume | 212,300 | ||
30-Day Average Volume | 225,611 | ||
1-Week Change | -6.88% | ||
1-Month Change | 4.85% | ||
1-Year Change | -8.98% | ||
3-Year Change | 198.83% | ||
5-Year Change | 78.52% | ||
Fundamentals | |||
Shares Outstanding | 21.1M | ||
Total Assets | $1.5B | ||
Market Cap | $772.0M | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $396.7M | ||
Net Income | $21.7M | ||
Free Cash Flow | $5.2M | ||
EBIT | $42.5M | ||
EBITDA | $55.9M | ||
Net Working Capital | $619.0M | ||
EPS | $0.53 | ||
Enterprise Value/EBITDA | 26 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 2 | ||
P/E | 67 | ||
PEG | -7 | ||
Price/Free Cash Flow | 144 | ||
Price/Operating Cash Flow | 31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.35% | ||
Trailing Annual Dividend Yield | 1.35% | ||
Ex-Dividend Date | 09/02/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield